2011 bis 1997

Sommer AP, Bieschke J, Friedrich RP, Zhu D, Wanker EE, Fecht HJ, Mereles D, Hunstein W. 670 nm Laser Light and EGCG Complementarily Reduce Amyloid-ß Aggregates in Human Neuroblastoma Cells: Basis for Treatment of Alzheimer's Disease? Photomed Laser Surg. 2011 Oct 26. [Epub ahead of print]

Mereles D, Hunstein W. Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises? Int J Mol Sci. 2011;12(9):5592-5603.

Mereles D, Buss SJ, Hardt SE, Hunstein W, Katus HA. Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis. Clin Res Cardiol. 2010;99(8):483-90.

Hauber I, Hohenberg H, Holstermann B, Hunstein W, Hauber J. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proc Natl Acad Sci U S A. 2009;106:9033-9038.

Hunstein W. Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option? Blood. 2007;110(6):2216.

Zierhut D, Lohr F, Schraube P, Huber P, Wenz F, Haas R, Fehrentz D, Flentje M, Hunstein W, Wannenmacher M. Cataract incidence after total-body irradiation. Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):131-5.

Lohr F, Wenz F, Schraube P, Flentje M, Haas R, Zierhut D, Fehrentz D, Hunstein W, Wannenmacher M. Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for hematological malignancies. Radiother Oncol. 1998 Jul;48(1):45-51.

Egerer G, Hegenbart U, Salwender H, Hahn U, Haas R, Goldschmidt H, Hunstein W. [Ambulatory therapy of multiple myeloma with vincristine, adriamycin and dexamethasone] Dtsch Med Wochenschr. 1997 Apr 25;122(17):531-5.

Dohner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, Fischer K, Hunstein W, Lichter P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood. 1997 Apr 1;89(7):2516-22.

Haas R, Schmid H, Hahn U, Hohaus S, Goldschmidt H, Murea S, Kaufmann M, Wannenmacher M, Wallwiener D, Bastert G, Hunstein W. Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer. Eur J Cancer. 1997 Mar;33(3):372-8.

1996 bis 1987

Haas R, Brittinger G, Meusers P, Murea S, Goldschmidt H, Wannenmacher M, Hunstein W. Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma. Leukemia. 1996 Dec;10(12):1975-9.

Goldschmidt H, Hegenbart U, Haas R, Hunstein W. Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma. Bone Marrow Transplant. 1996 May;17(5):691-7.

Haas R, Moos M, Mohle R, Dohner H, Witt B, Goldschmidt H, Murea S, Flentje M, Wannenmacher M, Hunstein W. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant. 1996 Feb;17(2):149-55.

Haas R, Hohaus S, Murea S, Schmid H, Wallwiener D, Bastert G, Wannenmacher M, Hunstein W. [Principle and foundations of high dose therapy with stem cell transplantation] Zentralbl Gynakol. 1996;118(10):575-7.

Goldschmidt H, Hahn U, Salwender HJ, Haas R, Jansen B, Wolbring P, Rinck M, Hunstein W. Prevention of catheter-related infections by silver coated central venous catheters in oncological patients. Zentralbl Bakteriol. 1995 Dec;283(2):215-23.

Moos M, Schulz R, Cremer F, Sucker C, Schmohl D, Dohner H, Goldschmidt H, Haas R, Hunstein W. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies. Stem Cells. 1995 Dec;13 Suppl 3:42-51.

Goldschmidt H, Hegenbart U, Moos M, Eugenhart R, Wannenmacher M, Haas R, Hunstein W. Sequential high-dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma. Stem Cells. 1995 Dec;13 Suppl 3:36-41.

Haas R, Murea S, Goldschmidt H, Dohner H, Moos M, Witt B, Eugenhart R, Wannenmacher M, Hunstein W. High-dose therapy with peripheral blood progenitor cell support in patients with non-Hodgkin's lymphoma. Stem Cells. 1995 Dec;13 Suppl 3:28-35.

Fiehn C, Prummer O, Gallati H, Heilig B, Hunstein W. Treatment of systemic mastocytosis with interferon-gamma: failure after appearance of anti-IFN-gamma antibodies. Eur J Clin Invest. 1995 Aug;25(8):615-8.

Keilholz U, Scheibenbogen C, Mohler T, Brossart P, Maclachlan D, Geueke AM, Jochim A, Hunstein W. Addition of dacarbazine or cisplatin to interferon-alpha/interleukin-2 in metastatic melanoma: toxicity and immunological effects. Melanoma Res. 1995 Aug;5(4):283-7.

Haas R, Witt B, Mohle R, Goldschmidt H, Hohaus S, Fruehauf S, Wannenmacher M, Hunstein W. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood. 1995 Jun 15;85(12):3754-61.

Scheibenbogen C, Mohler T, Haefele J, Hunstein W, Keilholz U. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load. Melanoma Res. 1995 Jun;5(3):179-81.

Sonntag KC, Schwarz-Eywill M, Hunstein W. Is interferon alpha a therapy for hepatitis B-associated polyarteritis nodosa? Br J Rheumatol. 1995 May;34(5):486-7.

Haas R, Moos M, Karcher A, Mohle R, Witt B, Goldschmidt H, Flentje M, Wannenmacher M, Hunstein W. [Sequential high-dose therapy in patients with low-malignity non-Hodgkin's lymphoma] Strahlenther Onkol. 1995 May;171(5):300-1.

Fruehauf S, Haas R, Conradt C, Murea S, Witt B, Mohle R, Hunstein W. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood. 1995 May 1;85(9):2619-26.

Mohler T, Willhauck M, Scheibenbogen C, Pawlita M, Bludau H, Brossart P, Hunstein W, Keilholz U. Restriction of T cell receptor V beta repertoire in melanoma metastasis responding to immunotherapy. Melanoma Res. 1995 Apr;5(2):129-32.

Haas R, Mohle R, Pforsich M, Fruehauf S, Witt B, Goldschmidt H, Hunstein W. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells. Blood. 1995 Apr 1;85(7):1936-43.

Fischer K, Dohner H, Hunstein W. [Enlarged lymph nodes] Hautarzt. 1995 Feb;46(2):131-9; quiz 139.

Hahn U, Goldschmidt H, Salwender H, Haas R, Hunstein W. Large-bore central venous catheters for the collection of peripheral blood stem cells. J Clin Apher. 1995;10(1):12-6.

Keilholz U, Scheibenbogen C, Brossart P, Mohler T, Tilgen W, Hunstein W. Interleukin-2-based immunotherapy and chemoimmunotherapy in metastatic melanoma. Recent Results Cancer Res. 1995;139:383-90.

Fiehn C, Pezzutto A, Hunstein W. Superficial migratory thrombophlebitis in a patient with reversible protein C deficiency and anticardiolipin antibodies. Ann Rheum Dis. 1994 Dec;53(12):843-4.

Haas R, Hohaus S, Goldschmidt H, Mohle R, Witt B, Wannenmacher M, Hunstein W. High-dose therapy and autografting with peripheral blood stem cells in malignant lymphoma: granulocyte-macrophage colony-stimulating factor for stem cell mobilization. Semin Oncol. 1994 Dec;21(6 Suppl 16):19-24.

Haas R, Moos M, Karcher A, Mohle R, Witt B, Goldschmidt H, Fruhauf S, Flentje M, Wannenmacher M, Hunstein W. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. J Clin Oncol. 1994 Aug;12(8):1685-92.

Frank C, Flentje M, Goldschmidt H, Hunstein W, Wannenmacher M. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma. Strahlenther Onkol. 1994 Jul;170(7):383-90.

Wulf G, Kluding H, Ho AD, Doerner M, Doehner H, Manegold C, Hunstein W. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis. Leuk Res. 1994 Jul;18(7):475-84.

Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 1994 Jun 15;83(12):3787-94.

Scheibenbogen C, Keilholz U, Mytilineos J, Suciu S, Manasterski M, Hunstein W. HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2). Melanoma Res. 1994 Jun;4(3):191-4.

Dohner H, Hunstein W. [Hairy cell leukemia] Dtsch Med Wochenschr. 1994 Apr 29;119(17):642.

Fischer K, Dohner H, Hunstein W. [Lymph node hyperplasia] Internist (Berl). 1994 Mar;35(3):301-9.

Keilholz U, Scheibenbogen C, Brado M, Georgi P, Maclachlan D, Brado B, Hunstein W. Regional adoptive immunotherapy with interleukin-2 and lymphokine-activated killer (LAK) cells for liver metastases. Eur J Cancer. 1994;30A(1):103-5.

Brossart P, Keilholz U, Scheibenbogen C, Mohler T, Willhauck M, Hunstein W. Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy. J Immunother Emphasis Tumor Immunol. 1994 Jan;15(1):38-41.

Keilholz U, Scheibenbogen C, Stoelben E, Saeger HD, Hunstein W. Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions. Eur J Cancer. 1994;30A(7):955-8.

Scheibenbogen C, Hunstein W, Keilholz U. Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patients. Eur J Cancer. 1994;30A(8):1209-11.

Haas R, Mohle R, Murea S, Goldschmidt H, Pforsich M, Witt B, Hunstein W. Characterization of peripheral blood progenitor cells mobilized by cytotoxic chemotherapy and recombinant human granulocyte colony-stimulating factor. J Hematother. 1994 Winter;3(4):323-30.

Fruehauf S, Haas R, Zeller WJ, Hunstein W. CD34 selection for purging in multiple myeloma and analysis of CD34+ B cell precursors. Stem Cells. 1994 Jan;12(1):95-102.

Haas R, Ho AD, Del Valle F, Fischer JT, Ehrhardt R, Dohner H, Witt B, Huberts H, Kaplan E, Hunstein W. Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia. Semin Oncol. 1993 Dec;20(6 Suppl 8):20-6.

Brossart P, Keilholz U, Willhauck M, Scheibenbogen C, Mohler T, Hunstein W. Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol. 1993 Dec;101(6):887-9.

Haas R, Ehrhardt R, Witt B, Goldschmidt H, Hohaus S, Pforsich M, Ehrlich H, Farber L, Hunstein W. Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma. Bone Marrow Transplant. 1993 Dec;12(6):643-9.

Heilig B, Pezzutto A, Lukoschek M, Hunstein W. [Expression of TNF receptors in rheumatoid arthritis and ankylosing spondylitis] Z Rheumatol. 1993 Nov-Dec;52(6):383-9.

Heilig B, Fiehn C, Brockhaus M, Gallati H, Pezzutto A, Hunstein W. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol. 1993 Sep;13(5):321-8.

Keilholz U, Scheibenbogen C, Tilgen W, Bergmann L, Weidmann E, Seither E, Richter M, Brado B, Mitrou PS, Hunstein W. Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials. Cancer. 1993 Jul 15;72(2):607-14.

Scheibenbogen C, Keilholz U, Meuer S, Dengler T, Tilgen W, Hunstein W. Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines. Int J Cancer. 1993 May 28;54(3):494-8.

Scheibenbogen C, Keilholz U, Pezzutto A, Hunstein W. Rheumatic disease following immunotherapy. Ann Rheum Dis. 1993 Feb;52(2):165.

Fruehauf S, Fiehn C, Haas R, Doehner H, Hunstein W. Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapy. Acta Haematol. 1993;89(2):91-3.

Haas R, Hohaus S, Ehrhardt R, Goldschmidt H, Hunstein W. Autologous blood progenitor cell transplantation in relapsed Hodgkin's disease--the role of haematopoietic growth factors. Bone Marrow Transplant. 1993;11 Suppl 2:30-5.

Haas R, Gericke G, Witt B, Cayeux S, Hunstein W. Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation. Exp Hematol. 1993 Jan;21(1):109-13.

Haas R, Hohaus S, Goldschmidt H, Witt B, Hunstein W. Hematopoietic growth factors for the mobilization of peripheral blood stem cells. J Hematother. 1993 Fall;2(3):357-9. Review.

Mohle R, Haas R, Hunstein W. Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood. J Hematother. 1993 Winter;2(4):483-9.

Brado B, Keilholz U, Tilgen W, Pezzutto A, Gissler M, Hunstein W. [Chilblain lupus erythematosus. A case report] Internist (Berl). 1992 Oct;33(10):701-3.

Haas R, Hohaus S, Egerer G, Ehrhardt R, Witt B, Hunstein W. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplant. 1992 Jun;9(6):459-65.

Ho AD, Moritz T, Rensch K, Hunstein W, Kirchner H. Deficiency in interferon production of peripheral blood leukocytes from patients with non-Hodgkin lymphoma. J Interferon Res. 1992 May;Spec No:61-9.

Keilholz U, Schlag P, Tilgen W, Brado B, Galm F, Gorich J, Kauffmann GW, Moller P, Schneider S, Hunstein W. Regional administration of lymphokine-activated killer cells can be superior to intravenous application. Cancer. 1992 Apr 15;69(8):2172-5.

Ho AD, Klotzbucher A, Gross A, Dietz G, Mestan J, Jakobsen H, Hunstein W. Induction of intracellular and plasma 2',5'-oligoadenylate synthetase by pentostatin. Leukemia. 1992 Mar;6(3):209-14.

Scheibenbogen C, Keilholz U, Richter M, Andreesen R, Hunstein W. The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75). Res Immunol. 1992 Jan;143(1):33-7.

Haas R, Hohaus S, Ehrhardt R, Ogniben E, Boschmann G, Witt B, Hunstein W. Autologous blood stem cell transplantation for patients with Hodgkin's disease in sensitive relapse. Prog Clin Biol Res. 1992;377:621-7.

Heilig B, Wermann M, Gallati H, Brockhaus M, Berke B, Egen O, Pezzutto A, Hunstein W. Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin Investig. 1992 Jan;70(1):22-7.

Bentz M, Dohner H, Guckel F, Semmler W, Kauczor HU, van Kaick G, Ho AD, Hunstein W. Assessment of bone marrow infiltration by magnetic resonance imaging in patients with hairy cell leukemia treated with pentostatin or alpha-interferon. Leukemia. 1991 Oct;5(10):905-7.

Weiss C, Wulf G, Ho AD, Hunstein W. Decrease in soluble CD8 antigen levels in splenectomized patients as an index for reduced suppressor/cytotoxic cell activity. Immunol Lett. 1991 Sep;30(1):113-8.

Korbling M, Knauf W, Funderud S, Kvalheim G, Hunstein W. Autologous transplantation of an immunomagnetic bead purged marrow in patients with relapsed acute lymphoblastic leukemia. Haematologica. 1991 Mar;76 Suppl 1:29-36.

Ho AD, Brado B, Haas R, Hunstein W. Etoposide in acute leukemia. Past experience and future perspectives. Cancer. 1991 Jan 1;67(1 Suppl):281-4. Review.

Keilholz U, Klein HG, Korbling M, Brado B, Carter CS, Cullis H, Galm F, Hunstein W. Peripheral blood mononuclear cell collection from patients undergoing adoptive immunotherapy or peripheral blood-derived stem cell transplantation and from healthy donors. J Clin Apher. 1991;6(3):131-6.

Ho AD, Haas R, Korbling M, Dietz M, Hunstein W. Utilization of recombinant human GM-CSF to enhance peripheral progenitor cell yield for autologous transplantation. Bone Marrow Transplant. 1991;7 Suppl 1:13-7.

Keilholz U, Dummer R, Welters H, Brado B, Galm F, Matheiowetz P, Hunstein W. A modified cytotoxicity assay with high sensitivity. Scand J Clin Lab Invest. 1990 Dec;50(8):879-84.

Trumper LH, von Baum H, Seitz HK, Hunstein W. [Menetrier's disease: brain infarction as an unusual first symptom] Schweiz Med Wochenschr. 1990 Nov 17;120(46):1737-40.

Ho AD, Pezzutto A, Hunstein W. [The therapy of hairy-cell leukemia] Dtsch Med Wochenschr. 1990 Oct 12;115(41):1556-9.

Pezzutto A, Ho AD, Hunstein W. [Diagnosis of hairy cell leukemia] Dtsch Med Wochenschr. 1990 Oct 5;115(40):1515-8.

Ho AD, Reichardt P, Gamm H, Hunstein W. Pleural involvement in hairy cell leukemia--development under alpha-interferon and remission upon pentostatin therapy. Leukemia. 1990 Oct;4(10):720-1.

Ho AD, Mannel DN, Wulf G, Kirchner H, Gundt A, Trede I, Rensch K, Hunstein W. Long-term effects of 2'-deoxycoformycin treatment on cytokine production in patients with hairy cell leukemia. Leukemia. 1990 Aug;4(8):584-9.

Korbling M, Holle R, Haas R, Knauf W, Dorken B, Ho AD, Kuse R, Pralle H, Fliedner TM, Hunstein W. Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. J Clin Oncol. 1990 Jun;8(6):978-85.

Stehle B, Weiss C, Ho AD, Hunstein W. Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor. Blood. 1990 May 1;75(9):1895-6.

Ho AD, Grossman M, Trumper L, Pezzutto A, Pralle H, Boedewadt-Radzun S, Papendick U, God B, Zwingers T, Hunstein W. Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia. Blood. 1990 Mar 1;75(5):1119-24.

Haas R, Ho AD, Bredthauer U, Cayeux S, Egerer G, Knauf W, Hunstein W. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol. 1990 Feb;18(2):94-8.

Weiss C, Ho AD, Hiller E, Thiel E, Schlag R, Lipp T, Herrmann R, Musch E, Termander B, Hunstein W. Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsiveness. Leuk Res. 1990;14(4):327-32.

Weiss C, Stehle B, Ho AD, Hunstein W. Serum levels of tumor necrosis factor-alpha in hairy cell leukemia. Blood. 1990 Jan 1;75(1):321-3.

Ho AD, Haas R, Wulf G, Knauf W, Ehrhardt R, Heilig B, Korbling M, Schulz G, Hunstein W. Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma. Blood. 1990 Jan 1;75(1):203-12.

Korbling M, Dorken B, Ho A, Haas R, Knauf W, Hunstein W. Long-term disease-free survival following autologous bone marrow/blood stem cell transplantation in 89 patients with acute leukemia. Haematol Blood Transfus. 1990;33:675-8.

Knauf WU, Ho AD, Korbling M, Hunstein W. Combination therapy with mitoxantrone and etoposide in adult acute myelogenous leukemia. Haematol Blood Transfus. 1990;33:314-5.

Korbling M, Haas R, Knauf W, Holle R, Hunstein W. Therapeutic efficacy of autologous blood stem cell transplantation (ABSCT): the role of cytotoxic/cytokine stem cell mobilization. Bone Marrow Transplant. 1990 Jan;5 Suppl 1:39-40.

Korbling M, Hunstein W, Fliedner TM, Cayeux S, Dorken B, Fehrentz D, Haas R, Ho AD, Keilholz U, Knauf W, et al. Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia. Blood. 1989 Nov 1;74(6):1898-904.

Trumper LH, Ho AD, Wulf G, Hunstein W. Addition of verapamil to overcome drug resistance in multiple myeloma: preliminary clinical observations in 10 patients. J Clin Oncol. 1989 Oct;7(10):1578-9.

Ho AD, del Valle F, Ruckle H, Schwammborn J, Schlimok G, Hiddemann W, Meusers P, Thiel E, Dorken B, Hunstein W. Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma. Cancer. 1989 Oct 1;64(7):1388-92.

Ho AD, Grossmann M, Knauf W, Martin H, Trumper L, Zwingers T, Sonnen R, Pralle H, Hunstein W. Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy. Leukemia. 1989 Oct;3(10):718-23.

Haas R, Hohaus S, Kiesel S, Ogniben E, Ehrhardt R, Hunstein W. Effect of recombinant human interleukin 2 (rIL-2) on normal peripheral blood B cells and B lymphoblastoid cell lines. Immunol Lett. 1989 Sep;22(3):239-45.

Dohner H, Guckel F, Knauf W, Semmler W, van Kaick G, Ho AD, Hunstein W. Magnetic resonance imaging of bone marrow in lymphoproliferative disorders: correlation with bone marrow biopsy. Br J Haematol. 1989 Sep;73(1):12-7.

Keilholz U, Korbling M, Fehrentz D, Bauer H, Hunstein W. Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders. Cancer. 1989 Aug 1;64(3):641-5.

Hufner M, Dohner H, Schmidt J, Moller P, Ho AD, Hunstein W. Evidence for an osteoblast-activating factor in a patient with peripheral T-cell lymphoma and osteosclerosis. Klin Wochenschr. 1989 Apr 3;67(7):402-7.

Haas R, Ogniben E, Kiesel S, Hohaus S, Baumann M, Korbling M, Dorken B, Hunstein W. Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor. Exp Hematol. 1989 Mar;17(3):235-9.

Kiesel S, Pezzutto A, Korbling M, Haas R, Schulz R, Hunstein W, Dorken B. Autologous peripheral blood stem cell transplantation: analysis of autografted cells and lymphocyte recovery. Transplant Proc. 1989 Feb;21(1 Pt 3):3084-8.

Trumper LH, Ho AD, Hunstein W, van der Lelie H, Goudsmit R. Therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. Blut. 1989 Feb;58(2):85-7.

Haas R, Hohaus S, Kiesel S, Ogniben E, Hunstein W. Effect of recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) on normal peripheral B lymphocytes and B lymphoblastoid cell lines. Immunol Lett. 1989 Jan 31;20(2):133-8.

Ho AD, Ganeshaguru K, Knauf W, Dietz G, Trede I, Hoffbrand AV, Hunstein W. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response. Leuk Res. 1989;13(4):269-78.

Wiedenmann B, Reichardt P, Rath U, Theilmann L, Schule B, Ho AD, Schlick E, Kempeni J, Hunstein W, Kommerell B. Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas. J Cancer Res Clin Oncol. 1989;115(2):189-92.

Ho AD, Ganeshaguru K, Knauf WU, Dietz G, Trede I, Hunstein W, Hoffbrand AV. Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo. Blood. 1988 Dec;72(6):1884-90.

Hunstein W, Trumper LH, Dummer R, Schwechheimer K. Glucagonoma syndrome and bronchial carcinoma. Ann Intern Med. 1988 Dec 1;109(11):920-1.

Haas R, Kiesel S, Ogniben E, Baumann M, Hohaus S, Korbling M, Dorken B, Hunstein W. The effect of human recombinant GM-CSF on the myelopoiesis in a long-term bone marrow culture (LTBMC). Behring Inst Mitt. 1988 Aug;(83):278-83.

Kiesel S, Pezzutto A, Moldenhauer G, Haas R, Korbling M, Hunstein W, Dorken B. B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation. Blood. 1988 Aug;72(2):672-8.

Mundinger A, Baldauf G, Hunstein W. [X-ray diagnosis of carcinosarcoma of the peripapillary duodenum] Rofo. 1988 Aug;149(2):212-3.

Ho AD, Moritz T, Rensch K, Hunstein W, Kirchner H. Deficiency in interferon production of peripheral blood leukocytes from patients with non-Hodgkin lymphoma. J Interferon Res. 1988 Aug;8(4):405-13.

Keilholz U, Welters H, Dummer R, Tilgen W, Hunstein W. [A new approach in the treatment of metastatic melanoma: adoptive immunotherapy using lymphokine-activated killer cells and interleukin 2] Hautarzt. 1988 Jun;39(6):378-81.

Ho AD, Lipp T, Ehninger G, Illiger HJ, Meyer P, Freund M, Hunstein W. Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen. J Clin Oncol. 1988 Feb;6(2):213-7.

Korbling M, Fehrentz D, Rother K, Hunstein W. [Collection and transplantation of hematopoietic stem cells of circulating blood] Beitr Infusionsther. 1988;21:322-34.

Ho AD, Kuse R, Prummer O, Porzsolt F, Hunstein W. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha. Klin Wochenschr. 1987 Oct 15;65(20):975-9.

Hunstein W, Ho AD. [Therapy in the myelodysplastic syndrome] Dtsch Med Wochenschr. 1987 Jan 9;112(2):62-4.

Hunstein W, Ho AD. [Diagnosis in the myelodysplastic syndrome] Dtsch Med Wochenschr. 1987 Jan 9;112(2):60-2.

Ho AD, Martin H, Knauf W, Reichardt P, Trumper L, Hunstein W. Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes. Leuk Res. 1987;11(11):1041-4.

Seitz M, Napierski I, Augustin R, Hunstein W, Kirchner H. Reduced production of interferon alpha and interferon gamma in leukocyte cultures from patients with active rheumatoid arthritis. Scand J Rheumatol. 1987;16(4):257-62.

Ho AD, Knauf W, Ganeshaguru K, Hunstein W, Hoffbrand AV. Purine degradative enzymes in circulating malignant cells of patients with chronic B cell neoplasia. Hematol Oncol. 1987 Jan-Mar;5(1):9-17.

1986 bis 1977

Frosch PJ, Weickel R, Deboben A, Hunstein W. [Delayed allergy following mesna] Dtsch Med Wochenschr. 1986 Dec 5;111(49):1901-2.

Ho AD, Lipp T, Ehninger G, Meyer P, Freund M, Hunstein W. Combination therapy with mitoxantrone and etoposide in refractory acute myelogenous leukemia. Cancer Treat Rep. 1986 Aug;70(8):1025-7.

Hufner M, Bohn T, Hunstein W. [Clinical diagnosis: Cushing's disease. Laboratory diagnosis: normal findings. A contribution on the rhythmic activity of endocrine adenomas] Internist (Berl). 1986 Aug;27(8):541-2.

Ho AD, Dietz G, Trede I, Schwartz R, Hoffbrand AV, Hunstein W. Enzymes of purine metabolism in hairy cell leukemia. Cancer. 1986 Jul 1;58(1):96-9.

Ho AD, Wittkamp S, Theml H, Keilholz U, Hunstein W. [Results with the use of the M-2 protocol in plasmacytoma] Dtsch Med Wochenschr. 1986 May 30;111(22):858-61.

Dorken B, Pezzutto A, Moldenhauer G, Schwartz R, Kiesel S, Hunstein W. An immunoenzymatic staining assay (ISA) for the rapid screening of monoclonal antibodies detecting membrane and cytoplasmic antigens. J Immunol Methods. 1986 Apr 3;88(1):129-36.

Ho AD, Dorken B, Ma DD, Pezzutto A, Hunstein W, Hoffbrand AV. Purine degradative enzymes and immunological phenotypes in chronic B-lymphocytic leukaemia: indications that leukaemic immunocytoma is a separate entity. Br J Haematol. 1986 Mar;62(3):545-55.

Korbling M, Dorken B, Ho AD, Pezzutto A, Hunstein W, Fliedner TM. Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood. 1986 Feb;67(2):529-32.

Korbling M, Hunstein W. [Autologous bone marrow transplantation in malignant lymphohematopoietic diseases] Ter Arkh. 1986;58(9):23-9. Russian.

Hunstein W, Ho AD. [Myelodysplasia--a newly defined preliminary stage of acute leukemia] Verh Dtsch Ges Inn Med. 1986;92:85-9.

Gless KH, Sutterlin U, Schaz K, Schutz V, Hunstein W. Intracellular sodium concentration and transport in red cells in essential hypertension, hyperthyroidism, pregnancy and hypokalemia. Clin Physiol Biochem. 1986;4(3):199-209.

Bohn T, Hunstein W. [Late recurrence of Wegener disease] Internist (Berl). 1985 Nov;26(11):711.

Haas R, Mundinger A, Bohn T, Schaz K, Hunstein W. [Therapeutic possibilities in hypereosinophilia syndrome with Loffler's fibroplastic endomyocarditis. Efficacy of cytarabine and 6-thioguanine] Dtsch Med Wochenschr. 1985 Oct 11;110(41):1573-6.

Ho AD, Kleckow M, Rix E, Hunstein W. Respiratory distress as primary symptom of relapse in a patient with non-Hodgkin lymphoma. Blut. 1985 Oct;51(4):287-9.

Seitz M, Hunstein W. Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus. Ann Rheum Dis. 1985 Jul;44(7):438-45.

Ho AD, Pezzutto A, Dorken B, Hunstein W, Schwechheimer K. [Plasmacytomas without paraproteins] Dtsch Med Wochenschr. 1985 May 31;110(22):874-7.

Bohn T, Hunstein W. [Bronchial asthma, eosinophilia and lung infiltrates (Churg-Strauss syndrome)] Schweiz Med Wochenschr. 1985 May 4;115(18):629-31.

Bohn T, Hunstein W, Ho AD. [Long-term observations of Wegener's disease. Results of treating recurrences] Dtsch Med Wochenschr. 1985 Apr 19;110(16):642-4.

Ho AD, Stehle B, Dietz G, Hunstein W, Hoffbrand AV. Terminal differentiation of cord blood lymphocytes induced by thymosin fraction 5 and thymosin alpha 1. Scand J Immunol. 1985 Mar;21(3):221-5.

132: Ho AD, Schwarz CE, Hunstein W. Treatment of acute myeloid leukemia developing after a myelodysplastic phase with low dose arabinosyl cytosine. Leuk Res. 1985;9(10):1293-8.

Job G, Pfreundschuh M, Bauer M, zum Winkel K, Hunstein W. The influence of radiation therapy on T-lymphocyte subpopulations defined by monoclonal antibodies. Int J Radiat Oncol Biol Phys. 1984 Nov;10(11):2077-81.

Ho AD, Dorken B, Hunstein W. [Biochemical markers in lymphatic neoplasms] Dtsch Med Wochenschr. 1984 Sep 7;109(36):1375-8.

Ho AD, Fiehn W, Hunstein W. Plasma and intracellular levels of lactate dehydrogenase, phosphohexose isomerase and lysozyme activity in acute leukemia. Blut. 1984 Jul;49(1):19-28.

Sutterlin U, Gless KH, Schaz K, Hufner M, Schutz V, Hunstein W. Peripheral effects of thyroid hormones: alteration of intracellular Na-concentration, ouabain-sensitive Na-transport, and Na-Li countertransport in human red blood cells. Klin Wochenschr. 1984 Jun 15;62(12):598-601.

Korbling M, Hunstein W. In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy. Blut. 1984 Apr;48(4):189-99.

Korbling M, Hunstein W, Fliedner TM. [Autologous bone marrow transplantation] Dtsch Med Wochenschr. 1984 Feb 17;109(7):265-71.

Seitz M, Vogt P, Muller W, Hunstein W, Gemsa D. Characterization of blood mononuclear cells of rheumatoid arthritis patients. II. Depressed PPD presentation by monocytes to T lymphocytes. Clin Immunol Immunopathol. 1983 Nov;29(2):242-53.

Ho AD, Ma DD, Price G, Hunstein W, Hoffbrand AV. Biochemical and immunological differentiation of human thymocytes induced by thymic hormones. Immunology. 1983 Nov;50(3):471-6.

Pfreundschuh M, Parino G, Gram N, Broker A, Gause A, Hunstein W. The influence of chrysotherapy on T-lymphocyte subpopulations in rheumatoid arthritis. Z Rheumatol. 1983 Nov-Dec;42(6):328-31.

Ho AD, Stojakowits S, Pralle H, Dorner M, Hunstein W. Glucocorticoid receptor level, terminal deoxynucleotidyl transferase activity and initial responsiveness to prednisone and vincristine in leukemia. Klin Wochenschr. 1983 May 2;61(9):455-9.

Korbling M, Dorken B, Tischbirek K, Zipperle G, Ho AD, Fliedner TM, Hunstein W. Autologous transplantation of a bone marrow graft manipulated by chemoseparation to eliminate residual tumor cells. Blut. 1983 Feb;46(2):89-93.

Pfreundschuh M, Gless KH, Dorken B, Vecsei P, Hunstein W. Effect of cytotoxic drugs on the function of the hypothalamo-pituitary-adrenal axis. Oncology. 1983;40(2):102-5.

Pfreundschuh M, Dorken B, Brandeis W, Hunstein W, Wernet P. Effect of neuraminidase treatment on serum reactivity to autologous leukemic blast cells. Cancer Immunol Immunother. 1983;15(3):194-9.

Seitz M, Deimann W, Gram N, Hunstein W, Gemsa D. Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol. 1982 Dec;25(3):405-16.

Roth E, Hunstein W, Seelig HP, Waldherr R, Roth E. [Immunohistological and histological findings in the temporal artery in polymyalgia rheumatica] Z Rheumatol. 1982 Nov-Dec;41(6):256-62.

Ho AD, Hunstein W. [Course and prognosis of leukemias] Lebensversicher Med. 1982 Sep 4;34(7):154-7.

Ho AD, Helmstadter V, Hunstein W. Immunocytochemical method for the detection of terminal deoxynucleotidyl transferase in acute leukemia. Klin Wochenschr. 1982 May 3;60(9):451-5. Review.

Ho AD, Fiehn W, Hunstein W. Intracellular lactic dehydrogenase and phosphohexose isomerase activity in leukaemia and malignant lymphoma. Br J Haematol. 1982 Apr;50(4):637-45.

Ho AD, Hunstein W, Ganeshaguru K, Hoffbrand AV, Brandeis WE, Denk B. Therapeutic and prognostic implications of glucocorticoid receptors and terminal deoxynucleotidyl transferase in acute leukemia. Leuk Res. 1982;6(1):1-8.

Pfreundschuh M, Michel H, Parino G, Gram N, Stock C, Gause A, Hunstein W. T-lymphocyte subpopulations in rheumatoid arthritis. II. Definition by monoclonal antibodies. Z Rheumatol. 1981 Nov-Dec;40(6):245-9.

Ho AD, Hunstein W, Uhl N, Storch HH. [Significance of terminal deoxynucleotidyl transferase in patients with acute leukemia and malignant lymphoma: results obtained by immunofluorescence assay (author's transl)] Dtsch Med Wochenschr. 1981 May 15;106(20):643-7.

Ho AD, Hunstein W, Schmid W. Glucocorticoid receptors and sensitivity in leukemias. Blut. 1981 Mar;42(3):183-90.

Zachoval R, Hunstein W, Ho AD. Progressive multifocal leukoencephalopathy in a patient with Hodgkin's disease. Blut. 1980 Dec;41(6):451-4.

Ho AD, Stojakowits S, Reitter B, Fiehn W, Zipperle G, Hunstein W, Lipinski C. Capping of lymphocytes in patients and carriers of Duchenne muscular dystrophy. Klin Wochenschr. 1980 Apr 1;58(7):377-81.

Ho AD, Hunstein W, Schmid W. Determination of glucocorticoid receptors in human leukemias. Klin Wochenschr. 1980 Jan 2;58(1):43-5.

Ho AD, Hunstein W, Dorken B, Pfreundschuh M, Kaufmann M, Kruger C. Leukocyte alkaline phosphatase in malignancies. Blut. 1979 Aug;39(2):141-5.

Zillessen E, Nessler G, Hunstein W. [Final remark on enteric Yersinia infection] Med Klin. 1979 May 25;74(21):839-40.

Ho AD, Hunstein W, Uhl N. [Acute myeloic leukemia as a late complication of Hodgkin's disease] MMW Munch Med Wochenschr. 1979 Apr 13;121(15):521-2.

Dorken B, Hunstein W. [Classification of malignant non-Hodgkin-lymphoma] Med Klin. 1979 Mar 9;74(10):337-47.

Zillessen E, Nessler G, Hunstein W. [Intestinal yersiniosis: 25 cases of infections with Yersinia pseudotuberculosis and Yersinia enterocolitica (author's transl)] Med Klin. 1978 Jun 16;73(24):901-9.

Hunstein W. [Clinical and clinico-chemical methods in early diagnosis] Verh Dtsch Ges Inn Med. 1978;(84):525-32.

Hunstein W, Gless KH, Schmidt-Gayk H, von Mittelstaedt G, Hufner M. Alkaline phosphatase and plasma-25-OH-vitamin D in hyperthyroidism. Horm Metab Res. 1977 Nov;9(6):532-3.

Gless KH, Hunstein W, Schmidt-Gayk H, Hufner M. [Serum 25-OH-vitamin D in patients with hyperthyroidism] Verh Dtsch Ges Inn Med. 1977 Apr 17-21;83:1364-7.

Zillessen E, Frerichs F, Herzfeld U, Bader R, Hunstein W. [Iron absorption after oral application of a combination of Fe2+-succinate and multivitamins (author's transl)] Arzneimittelforschung. 1977;27(8):1606-8.

Helmstadter V, Arnold H, Blume KG, Uhl N, Hunstein W. Acquired pyruvate kinase deficiency with hemolysis in preleukemia. Acta Haematol. 1977;57(6):339-43.

Hunstein W. Die Poliklinik im Dienst der ärztlichen Versorgung. Universitas. 1977;32:189-195.

1976 bis 1967

Uhl N, Hunstein W, Rehn K. [Proceedings: Hematopoiesis in chronic pyelonephritis. Quantitative-morphological study] Schweiz Med Wochenschr. 1975 Dec 20;105(51):1768-70.

Zillessen E, Rehn K, Hunstein W. [Enteral yersiniosis. Mesenteric lymphadenitis] Med Klin. 1975 Oct 10;70(41):1655-9.

Rehn K, Hunstein W. [Measurement of cell migration. A new method, also for routine diagnosis] Med Klin. 1975 Jun 13;70(24):1021-30.

Hunstein W. Experimental myelofibrosis. Clin Haematol. 1975 Jun;4(2):457-78.

Rehn K, Baake H, Hunstein W. [A simplified macrophage migration inhibition test to measure T-cell derived immunity in man] Klin Wochenschr. 1975 Apr 15;53(8):397-9.

Hunstein W, Rehn K. [Tumor-induction through cytostatic agents in man] Dtsch Med Wochenschr. 1975 Jan 24;100(4):155-8.

Rehn K, Matthiensen R, Keintzel E, Hunstein W, Uhl N. [Studies on delayed insulin allergy using cell-migration-inhibition technics in diabetics] Verh Dtsch Ges Inn Med. 1975;81:1504-6.

Hunstein W. [Isolated aplastic anemia] Hamatol Bluttransfus. 1975;16:161-9.

Hunstein W. Tumor inductions by cytostatics in man. Recent Results Cancer Res. 1975;(52):50-6.

Hunstein W. Die Vernunft im Dienst der Gesellschaft. Universitas. 1974;29:799-807.

Keyssner J, Hauswaldt C, Uhl N, Hunstein W. [Testosterone treatment of renal anemia. Evaluation of success by means of morphometric bone marrow and erythrocyte volume determinations] Schweiz Med Wochenschr. 1974 Dec 28;104(52):1938-41.

Hunstein W, Hauswaldt C. [Myelofibrosis (author's transl)] Klin Wochenschr. 1974 Apr 1;52(7):305-17.

Hunstein W. [Therapeutic considerations in chronic myeloid leukemia] Med Klin. 1974 Mar 8;69(10):412-6.

Zillessen E, Bach R, Schreiter B, Hunstein W. [Demonstration of hepatitis B-antigen in hospital personnel] Verh Dtsch Ges Inn Med. 1974;80:467-9.

Hunstein W. [Significance of preventive examinations from a hematological viewpoint] Internist (Berl). 1973 Feb;14(2):58-9.

Uhl N, Hunstein W, Rehn K. [Influence of dialysis on erythropoiesis-inhibiting effect of uermia serum] Verh Dtsch Ges Inn Med. 1973;79:453-5.

Scholz G, Rehn K, Hunstein W. [Hodgkin's sarcoma in immunosuppressive treated erythematosus visceralis] Verh Dtsch Ges Inn Med. 1973;79:1376-9.

Hunstein W. [Therapy of chronic myeloic leukemia] Verh Dtsch Ges Inn Med. 1973;79:334-9.

Rehn K, Hunstein W, Schreiter B, Uhl N. [Immunoglobulin determination in hematologic system diseases] Verh Dtsch Ges Inn Med. 1971;77:1397-400.

Perings E, Hunstein W, Schumann E. [Liver regeneration during azathioprine therapy. Animal experiment studies on partially hepatectomized rats] Verh Dtsch Ges Inn Med. 1971;77:1306-8.

Uhl N, Hunstein W. [Effect of erythropoietin in kidney diseases] Verh Dtsch Ges Inn Med. 1971;77:681-4.

Schmidt H, Uhl N, Hunstein W. [Isolated aplastic anemia (acute benign erythroblastopenia of Gasser) in ulcerative colitis] Med Klin. 1970 Apr 17;65(16):772-6.

Kattermann R, Worner R, Brunner G, Hunstein W. [Liver lesions and lipid metabolism. I. Lipid, bilirubin and enzyme activities in plasma in experimental cholestasis in rats] Acta Hepatosplenol. 1970 Jan-Feb;17(1):36-47.

Cohrs U, Hauswaldt C, Hunstein W. [The modification of experimental bone marrow fibrosis after repeated administration of foreign proteins by antiphlogistics and prednisolone acetate] Blut. 1969 Oct;19(7):394-404.

Uhl N, Eberle P, Quellhorst E, Schmidt R, Hunstein W. Busulfan treatment in pregnancy. A case report with chromosome studies. Ger Med Mon. 1969 Aug;14(8):383-7.

Wilbert L, Hillmer T, Hunstein W, Reisert P, Kaboth U, Creutzfeldt W. [Influence of ovulation inhibitors on clinicochemical norms] Dtsch Med Wochenschr. 1969 Apr 18;94(16):844-9.

Uhl N, Hunstein W. [Seasonal variations of the onset of lymphogranuloma] Arch Klin Med. 1969;216(4):355-70.

Hunstein W, Perings E, Eggeling B, Uhl N. [Panmyelophthisis and viral hepatitis. Experimental study with the MHV3 mouse hepatitis virus] Acta Haematol. 1969;42(6):336-46.

Hauswaldt C, Emmrich J, Hunstein W. [Osteoporosis, osteolysis and osteosklerosis on the roentgenogram in plasmocytoma and Waldenstroem's disease] Med Klin. 1968 Nov 1;63(44):1756-7.

Uhl N, Eberle P, Quellhorst E, Schmidt R, Hunstein W. [Myleran therapy in pregnancy. A case contribution with chromosome examination] Dtsch Med Wochenschr. 1968 Sep 27;93(39):1856-8.

Perings E, Hunstein W, Creutzfeldt W. [Preliminary results of immunosuppressive treatment in chronic liver diseases] Dtsch Z Verdau Stoffwechselkr. 1968;28(2):209-12.

Uhl N, Hunstein W, Kluthe R. [Serum haptoglobin as index of chronic hemolysis before and after operative correction of valvular heart disease] Arch Klin Med. 1968;215(2):133-49.

Perings E, Hunstein W, Creutzfeldt W. [Preliminary results of immunosuppressive therapy in chronic liver diseases] Verh Dtsch Ges Inn Med. 1968;74:894-7.

Eberle P, Hunstein W, Perings E. Chromosomes in patients treated with Imuran. Humangenetik. 1968;6(1):69-73.

Hunstein W. [Indications for the histological bone marrow examination] Hamatol Bluttransfus. 1968;4:31-42.

Hauswaldt C, Hunstein W, Cohrs U. [Animal experimental production of bone marrow fibroses through continuous injections of ovalbumin in the rabbit] Schweiz Med Wochenschr. 1967 Nov 4;97(44):1471-2.

Hunstein W, Hauswaldt C, Hunecke H. [Animal experimental production of sclerosing bone marrow fibroses following injection of heterologous antibodies in the rabbit] Klin Wochenschr. 1967 Jul 1;45(13):679-81.

Hauswaldt C, Hunstein W, Perings E. Amidopyrine agranulocytosis accompanied by erythroblast depression. A case report with skin-test results. Ger Med Mon. 1967 Jun;12(6):265-8.

Hunstein W, Reisert PM. [Behavior of the bone marrow in experimental protein deficiency anemia under treatment with anabolic steroids] Blut. 1967 Jun;15(3):142-8.

Hauswaldt C, Hunstein W, Uhl N, Doering P. [Histologic bone marrow findings in polycythemia vera before and after P32 therapy. (At the same time a contribution to the differential diagnosis of the clinical feature "polycythemia")] Arch Klin Med. 1967;213(3):219-36.

Hunstein W, Perings E, Klose E. [Long-time animal experiments with azathioprine (imuran) for the testing of its myelotoxic effect] Verh Dtsch Ges Inn Med. 1967;73:450-3.

Uhl N, Hauswaldt C, Hunstein W. [Seasonal distribution of the 1st manifestations of lymphogranulomatosis] Verh Dtsch Ges Inn Med. 1967;73:329-33.

Bergmann G, Eger W, Gregl A, Hunstein W, Knust S. [Animal experiment studies on the effect of cytostatic ointments. 3] Strahlentherapie. 1967 Jan;132(1):98-104.

Klemm D, Grusnick D, Weinreich J, Hauswaldt C, Hunstein W. [Paraproteinemia and plasma reticulum cell proliferation in polycythemia vera] Acta Haematol. 1967;38(4):240-9.

Hauswaldt C, Raju S, Bianchi L, Hunstein W. [A case contribution to the diagnosis of acute eosinophilic leukemia] Acta Haematol. 1967;37(2):143-9.

1966 bis 1957

Hauswaldt C, Hunstein W, Perings E. [Aminopyrine agranalucytosis with simultaneous erythroblastopenia. Contribution to case reports and intracutaneous allergen testing] Dtsch Med Wochenschr. 1966 Oct 14;91(41):1832-6.

Hunstein W, Hort W. [On the clinical picture of scarred inflammation of the bone marrow (Rohr's interstitial myelitis with myelofibrosis)] Schweiz Med Wochenschr. 1966 Sep 17;96(37):1223-5.

Hunstein W, Hotes C, Koncz J. [Increased hemolysis after heart operations] Med Klin. 1966 Sep 9;61(36):1414-8.

Hunstein W. [The importance of Burkitt tumors in leukemia research] Med Klin. 1966 May 13;61(19):741-3.

Reincke U, Stutz E, Hunstein W. [Tumor incidence and shortening of life in white rats following fractional roentgen total-body irradiation] Strahlentherapie. 1965 Nov;128(3):425-40.

Wendt F, Doyen A, Schoop W, Schubothe H, Hunstein W, Fliedner TM, Wedler HW. [Erythroblastophthisis in thymoma. Report on 2 observations with remission] Schweiz Med Wochenschr. 1965 Oct 30;95(44):1494-9.

Hunstein W. [Is Myleran (busulfan) a leukemogenic substance?] Schweiz Med Wochenschr. 1965 Oct 23;95(43):1437-9.

Klemm D, Hunstein W, Harwerth HG. [On the classification of atypical paraproteinemic hemoblastoses] Blut. 1965 Jul;11(4):208-33.

Hunstein W, Harwerth HG, Raju S. [Bioptic studies on the problem of therapy-induced bone marrow fibroses in chronic myeloid leukemia.] Med Klin. 1965 Jun 18;60:991-5.

Hunstein W, Strey M. [On the effect of prednisolone on the H3-thymidine incorporation rate into bone marrow cells of rats.] Klin Wochenschr. 1965 Jan 1;43:52-3.

Reincke U, Hunstein W, Stutz E. [Effect of acute blood loss on the tumor incidence in Roentgen-irradiated rats.] Z Krebsforsch. 1964 Nov 2;66:379-88.

Klemm D, Hunstein W, Langendorff H. [Atypical macroglobulins in plasmocytoma.] Dtsch Med Wochenschr. 1964 May 1;89:877-83.

Hunstein W, Stutz E, Reincke U. [Radiation-induced leukemia in wistar rats after fractionated total-body irradiation.] Blut. 1963 Dec;9:389-404.

Hunstein W. [New results in leukemia research.] Med Klin. 1963 Jul 12;58:1141-5.

Reisert P, Hunstein W. [The effect of anabolic steroids on protein-deficiency anemia in rats.] Klin Wochenschr. 1963 Apr 1;41:339.

Hunstein W, Wendt F. [Bone-marrow biopsy according to Turkel and Bethell.] Dtsch Med Wochenschr. 1962 Nov 16;87:2358-61.

Reisert PM, Hunstein W, Kiefer H. [16-Methyleneprednisolone (Decortilen) from a clinical viewpoint.] Munch Med Wochenschr. 1962 May 25;104:1003-9.

Altmann HW, Hunstein W, Stutz E. [On lung changes and lung tumors in rats after irradiation with radioactive strontium (Sr 90).] Beitr Pathol Anat. 1961;124:145-75.

Hunstein W. [Changes in the rat liver after irradiation with radioactive strontium (Sr-90).] Beitr Pathol Anat. 1960;122:345-62.

Hunstein W. [On an unusual heart injury.] Beitr Pathol Anat. 1959;121:114-23.

Heilmeyer L, Mossner G, Hunstein W. [Lymphogranulomatosis; symptomatology & results of therapy in 200 cases.] Dtsch Med Wochenschr. 1957 Jun 28;82(26):1046-50.